Literature DB >> 11882905

Expression of a decorin-like moleculein human melanoma.

A Ladányi1, M Gallai, S Paku, J O Nagy, J Dudás, J Tímár, I Kovalszky.   

Abstract

Decorin, a member of the family of small leucin-rich proteoglycans, has originally been described as a secreted proteoglycan component of the connective tissues, and has been implicated in the negative regulation of cell proliferation directly or via interactions with TGF-beta. It was reported to be generally absent from tumor cells. Here we show that human melanoma cell lines express a decorin-like molecule. We detected decorin mRNA by RT-PCR in 7 out 7 human melanoma lines characterized by various metastatic potential. Using polyclonal antiserum against the core protein of decorin, the typical 80-120 kD glycanated form as well as a high molecular weight aberrant version (200-210 kD) of decorin were demonstrated by Western blot technique in the culture supernatants as well as in lysates of human melanoma cells. Finally, decorin epitope was also demonstrated immunohistochemically in human melanoma xenografts, as well as in tumor cells of surgically resected melanomas but not in melanocytes of nevi. The expression of this aberrant decorin did not inhibit the in vitroor in vivogrowth of human melanoma cells, and it was independent of their metastatic potential. Human melanoma cell lines expressing aberrant decorin retained sensitivity to the antiproliferative and gelatinase-stimulatory effects of exogenous TGF-beta.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11882905     DOI: 10.1007/bf03032382

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  27 in total

1.  Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases.

Authors:  M Santra; D M Mann; E W Mercer; T Skorski; B Calabretta; R V Iozzo
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

Review 2.  Cell surface chondroitin sulfate proteoglycans in tumor cell adhesion, motility and invasion.

Authors:  J Iida; A M Meijne; J R Knutson; L T Furcht; J B McCarthy
Journal:  Semin Cancer Biol       Date:  1996-06       Impact factor: 15.707

Review 3.  The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth.

Authors:  R V Iozzo
Journal:  Crit Rev Biochem Mol Biol       Date:  1997       Impact factor: 8.250

4.  Preferential gene expression in quiescent human lung fibroblasts.

Authors:  D L Coppock; C Kopman; S Scandalis; S Gilleran
Journal:  Cell Growth Differ       Date:  1993-06

5.  Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.

Authors:  M R Bani; J Rak; D Adachi; R Wiltshire; J M Trent; R S Kerbel; Y Ben-David
Journal:  Cancer Res       Date:  1996-07-01       Impact factor: 12.701

6.  Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases.

Authors:  A De Luca; M Santra; A Baldi; A Giordano; R V Iozzo
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

7.  Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.

Authors:  W A Border; N A Noble; T Yamamoto; J R Harper; Y u Yamaguchi; M D Pierschbacher; E Ruoslahti
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

8.  Differential expression of proteoglycans on the surface of human melanoma cells characterized by altered experimental metastatic potential.

Authors:  J Timar; A Ladanyi; K Lapis; M Moczar
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

9.  Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan.

Authors:  G Pluschke; M Vanek; A Evans; T Dittmar; P Schmid; P Itin; E J Filardo; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

10.  Transcriptional regulation of decorin gene expression. Induction by quiescence and repression by tumor necrosis factor-alpha.

Authors:  A Mauviel; M Santra; Y Q Chen; J Uitto; R V Iozzo
Journal:  J Biol Chem       Date:  1995-05-12       Impact factor: 5.157

View more
  4 in total

1.  Sensitivity of Melanoma Cells to EGFR and FGFR Activation but Not Inhibition is Influenced by Oncogenic BRAF and NRAS Mutations.

Authors:  Tamás Garay; Eszter Molnár; Éva Juhász; Viktória László; Tamás Barbai; Judit Dobos; Karin Schelch; Christine Pirker; Michael Grusch; Walter Berger; József Tímár; Balázs Hegedűs
Journal:  Pathol Oncol Res       Date:  2015-03-09       Impact factor: 3.201

2.  Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding.

Authors:  Gerdy B ten Dam; Els M A van de Westerlo; Anurag Purushothaman; Radu V Stan; Johan Bulten; Fred C G J Sweep; Leon F Massuger; Kazuyuki Sugahara; Toin H van Kuppevelt
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

3.  Prenylation inhibition-induced cell death in melanoma: reduced sensitivity in BRAF mutant/PTEN wild-type melanoma cells.

Authors:  Tamás Garay; István Kenessey; Eszter Molnár; Éva Juhász; Andrea Réti; Viktória László; Anita Rózsás; Judit Dobos; Balázs Döme; Walter Berger; Walter Klepetko; József Tóvári; József Tímár; Balázs Hegedűs
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

4.  Melanoma Cell Adhesion and Migration Is Modulated by the Uronyl 2-O Sulfotransferase.

Authors:  Katerina Nikolovska; Dorothe Spillmann; Jörg Haier; Andrea Ladányi; Christian Stock; Daniela G Seidler
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.